Genome Analysis Offers New Hope For Severe Skin Condition
A significant breakthrough has been made by researchers from the National Institutes of Health (NIH) in collaboration with scientists from the University of California...
Vorasidenib – A Potential Game-Changer In Glioma Treatment
The University of California scientists have discovered a new targeted therapy drug that can extend the treatment duration for individuals with a specific subtype...
Adapting To The Changing Virus By Enhancing Vaccine Immunity
A report has been published by international regulators that highlights the outcomes of the discussion they had pertaining to COVID-19 vaccines, as well as...
UK Boosts Life Sciences Sector With £650 Million Funding
The UK chancellor has gone on to announce a £650 million growth package in life sciences so as to help in delivering the science...
Chinese Market Regulator Fines Two Monopolistic Pharma Firms
Two pharmaceutical companies for monopolistic behaviour have been penalized by the Chinese regulator. It has put a fine on Grand Pharmaceuticals for 136 million...
Enhancing Patient Care In The UK Through Recognition Routes
The medicines and healthcare products regulatory agency has gone on to announce that the new global regulatory recognition routes for drugs will be established...
Battling Global Medicine Shortages With EMA Recommendations
The European Medicines Agency has published recommendations to tackle medicine shortages and their associated repercussions. These recommendations emphasize the importance of ensuring the availability...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...